To request a free sample copy of this report, please complete the form below.
What people say about us!

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

logos logos logos logos logos
Analyst Support
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Global Cancer Therapeutics Market size was valued at USD 136.6 Billion in 2022 and is poised to grow from USD 149.02 Billion in 2023 to USD 299.13 Billion by 2031, at a CAGR of 9.1% during the forecast period (2024-2031).

The global cancer therapeutics market is highly competitive and constantly evolving, with numerous pharmaceutical and biotechnology companies driving innovation in cancer treatment.  Major players in the market are investing heavily in oncology R&D, focusing on novel drug candidates and innovative treatment modalities. These companies often collaborate with academic institutions and research organisations to explore new avenues for cancer treatment. Additionally, startups bring fresh perspectives and cutting-edge technologies to the market. The intense competition in the global cancer therapeutics market is ultimately beneficial for patients, as it fosters a dynamic environment that drives advancements in treatment options, improves patient outcomes, and brings new hope to those affected by cancer. 'Roche Holding AG (Switzerland) ', 'Novartis AG (Switzerland) ', 'Merck & Co., Inc. (USA) ', 'Pfizer Inc. (US) ', 'AstraZeneca plc (UK) ', 'Bristol Myers Squibb Company (USA) ', 'AbbVie Inc. (USA) ', 'Amgen Inc. (USA) ', 'GlaxoSmithKline plc (United Kingdom) ', 'Eli Lilly and Company ', 'Takeda Pharmaceutical Company Limited (Japan) ', 'Sanofi S.A. (France) ', 'Gilead Sciences, Inc. (USA) ', 'Bayer AG (Germany) ', 'Johnson & Johnson USA ', 'AbilityPharma (Spain) ', 'Adcendo (Denmark) ', 'Beroni Group (Australia) ', 'BioAtla (USA) ', 'Astellas Pharma Inc. (Japan)'

North America is the largest region in the cancer therapeutics market. North America, comprising the United States and Canada, holds a dominant position in the global cancer therapeutics market. This dominance can be attributed to several factors, including a high prevalence of cancer, well-established healthcare infrastructure, a strong emphasis on research and development, and a favourable regulatory environment. North America is home to some of the world's leading pharmaceutical and biotechnology companies, continuously investing in oncology research to develop innovative and effective cancer therapies. Additionally, the region has witnessed significant advancements in precision medicine and personalised treatment approaches, further contributing to its dominant position in the market.

Feedback From Our Clients

Global Cancer Therapeutics Market

Product ID: SQMIG35H2214